Polymeric nanoparticles for drug delivery: Recent developments and future prospects
B Begines, T Ortiz, M Pérez-Aranda, G Martínez… - Nanomaterials, 2020 - mdpi.com
The complexity of some diseases—as well as the inherent toxicity of certain drugs—has led
to an increasing interest in the development and optimization of drug-delivery systems …
to an increasing interest in the development and optimization of drug-delivery systems …
Ocular benzalkonium chloride exposure: problems and solutions
MH Goldstein, FQ Silva, N Blender, T Tran, S Vantipalli - Eye, 2022 - nature.com
Preservatives in multidose formulations of topical ophthalmic medications are crucial for
maintaining sterility but can be toxic to the ocular surface. Benzalkonium chloride (BAK) …
maintaining sterility but can be toxic to the ocular surface. Benzalkonium chloride (BAK) …
Considerations for polymers used in ocular drug delivery
MM Allyn, RH Luo, EB Hellwarth… - Frontiers in …, 2022 - frontiersin.org
Purpose Age-related eye diseases are becoming more prevalent. A notable increase has
been seen in the most common causes including glaucoma, age-related macular …
been seen in the most common causes including glaucoma, age-related macular …
Lipid nanoparticles as a promising drug delivery carrier for topical ocular therapy—an overview on recent advances
Due to complicated anatomical and physical properties, targeted drug delivery to ocular
tissues continues to be a key challenge for formulation scientists. Various attempts are …
tissues continues to be a key challenge for formulation scientists. Various attempts are …
[HTML][HTML] Strategies to prolong the residence time of drug delivery systems on ocular surface
Ocular diseases may be treated via different routes of administration, such as topical,
intracameral, intravitreal, oral and parenteral. Among them the topical route is most accepted …
intracameral, intravitreal, oral and parenteral. Among them the topical route is most accepted …
Hydrogel biomaterials for application in ocular drug delivery
CR Lynch, PPD Kondiah, YE Choonara… - … in bioengineering and …, 2020 - frontiersin.org
There are many challenges involved in ocular drug delivery. These are a result of the many
tissue barriers and defense mechanisms that are present with the eye; such as the cornea …
tissue barriers and defense mechanisms that are present with the eye; such as the cornea …
Chitosan and its derivatives for ocular delivery formulations: Recent advances and developments
A Zamboulis, S Nanaki, G Michailidou, I Koumentakou… - Polymers, 2020 - mdpi.com
Chitosan (CS) is a hemi-synthetic cationic linear polysaccharide produced by the
deacetylation of chitin. CS is non-toxic, highly biocompatible, and biodegradable, and it has …
deacetylation of chitin. CS is non-toxic, highly biocompatible, and biodegradable, and it has …
Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery
M Singh, S Bharadwaj, KE Lee, SG Kang - Journal of Controlled Release, 2020 - Elsevier
The eye is the specialized part of the body and is comprised of numerous physiological
ocular barriers that limit the drug absorption at the action site. Regardless of various efforts …
ocular barriers that limit the drug absorption at the action site. Regardless of various efforts …
Hydroxypropyl methylcellulose: Physicochemical properties and ocular drug delivery formulations
LL Tundisi, GB Mostaço, PC Carricondo… - European Journal of …, 2021 - Elsevier
Hydroxypropyl methylcellulose (HPMC) is a cellulose ether widely used in drug formulations
due to its biocompatibility, uncharged nature, solubility in water and thermoplastic behavior …
due to its biocompatibility, uncharged nature, solubility in water and thermoplastic behavior …
Soft contact lenses as drug delivery systems: a review
I Rykowska, I Nowak, R Nowak - Molecules, 2021 - mdpi.com
This review describes the role of contact lenses as an innovative drug delivery system in
treating eye diseases. Current ophthalmic drug delivery systems are inadequate, particularly …
treating eye diseases. Current ophthalmic drug delivery systems are inadequate, particularly …